PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Isopropamide→

Isopropamide PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
7492-32-2
Molecular formula
C23H33N2O+
Molecular weight
353.5 g/mol
Drug class
Quaternary ammonium antimuscarinicgastrointestinal antispasmodic (historical)
Mechanism of action
Competitively antagonises muscarinic acetylcholine receptors in gastrointestinal smooth muscle, reducing cholinergic tone, motility and spasm. Its quaternary ammonium structure limits central nervous system penetration.
Indications / reported uses
  • Historically used for symptomatic relief of gastrointestinal hypermotility and spasm in countries where isopropamide products were authorised; availability and current indications are jurisdiction-specific

Sources: NLM MeSH — Isopropamide · PubMed — Isopropamide anticholinergic pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Isopropamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Isopropamide Permitted Daily Exposure (PDE) report (the Isopropamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Isopropamide Occupational Exposure Limit (OEL) report (the Isopropamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.